12 December 2025
Novo Nordisk: EMA Recommends Higher Wegovy® Dose for 20.7% Weight Loss
EMA backs Wegovy® 7.2 mg for obesity, showing 20.7% weight loss in trials, preserving muscle, and reducing cardiovascular risks. Approval pending in EU, US, UK, and more.